SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-24-011587
Filing Date
2024-02-08
Accepted
2024-02-08 16:05:11
Documents
14
Period of Report
2024-02-02
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea193188-8k_chinapharma.htm   iXBRL 8-K 27538
  Complete submission text file 0001213900-24-011587.txt   203210

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE cphi-20240202.xsd EX-101.SCH 3048
3 XBRL LABEL FILE cphi-20240202_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE cphi-20240202_pre.xml EX-101.PRE 22381
15 EXTRACTED XBRL INSTANCE DOCUMENT ea193188-8k_chinapharma_htm.xml XML 3707
Mailing Address 2ND FLOOR, NO. 17, JINPAN ROAD HAIKOU HAINAN PROVINCE F4 570216
Business Address 2ND FLOOR, NO. 17, JINPAN ROAD HAIKOU HAINAN PROVINCE F4 570216 8689866811730
CHINA PHARMA HOLDINGS, INC. (Filer) CIK: 0001106644 (see all company filings)

IRS No.: 731564807 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34471 | Film No.: 24608975
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)